S. Noguchi et al., Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase, J BIOL CHEM, 275(4), 2000, pp. 2376-2380
Guanabenz, a metabolism-based irreversible inactivator of neuronal nitric-o
xide synthase (nNOS) in vitro, causes the loss of immunodetectable nNOS in
vivo. This process is selective in that the slowly reversible inhibitor NG-
nitro-L-arginine did not decrease the levels of nNOS in vivo. To better und
erstand the mechanism for the loss of nNOS protein in vivo we have investig
ated the effects of guanabenz and N-G-nitro-L-arginine in HEB: 293 cells st
ably transfected with the enzyme. me show here that guanabenz, but not N-G-
nitro-L-arginine, caused the inactivation and loss of nNOS protein in the H
ER 293 cells. in studies with cycloheximide or in pulse-chase experiments w
ith [S-35]methionine, we demonstrate that the loss of nNOS was due in large
part to enhanced proteolysis of the protein with the half-life decreasing
by one-half from 20 to 10 h. Other metabolism-based irreversible inactivato
rs to nNOS, N-G-methyl-L-arginine, and N-5-(1-iminoethyl)-L-ornithine, but
not the reversible inhibitor 7-nitroindazole (7-NI), caused a similar decre
ase in the half-life of nNOS, Proteasomal inhibitors, lactacystin, Cbz-leuc
ine-leucine-leucinal, and N-acetyl-leucine-leucine-norleucinal, but not the
lysosomal protease inhibitor leupeptin, were found to effectively inhibit
the proteolytic degradation of nNOS, Thus Fee have shown for the first time
that the irreversible inactivators of nNOS, perhaps through covalent alter
ation of the enzyme, enhance the proteolytic turnover of the enzyme by a me
chanism involving the proteasome.